ASCO 2020: DESTINY-Gastric01 trial reveals positive outlook for the treatment of HER2 positive gastric cancer patients with Enhertu

gastriccancer
It remains to be determined how Enhertu will compete with Herceptin in gastric cancer. Credit: Shutterstock + crystal light